Results 11 to 20 of about 13,113,839 (405)

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2020
Importance Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate disease is unknown.
C. Spinner   +29 more
semanticscholar   +1 more source

Novel indicator for the spread of new coronavirus disease 2019 and its association with human mobility in Japan

open access: yesScientific Reports, 2023
The Japanese government adopted policies to control human mobility in 2020 to prevent the spread of severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19). The present study examined the impact of human mobility
Yuta Kawakami   +6 more
doaj   +1 more source

Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial

open access: yesmedRxiv, 2020
Aims: Studies have indicated that chloroquine (CQ) shows antagonism against COVID-19 in vitro. However, evidence regarding its effects in patients is limited.
Zhaowei Chen   +8 more
semanticscholar   +1 more source

A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial

open access: yesTrials, 2020
Objectives Primary objective: to evaluate the efficacy of melatonin as a prophylactic treatment on prevention of symptomatic SARS-CoV-2 infection among healthcare workers at high risk of SARS-CoV-2 exposure. Secondary objectives: To evaluate the efficacy
Irene García García   +13 more
doaj   +1 more source

Comparison of Bayesian and frequentist group-sequential clinical trial designs [PDF]

open access: yes, 2020
Background: There is a growing interest in the use of Bayesian adaptive designs in late-phase clinical trials. This includes the use of stopping rules based on Bayesian analyses in which the frequentist type I error rate is controlled as in frequentist
Gates, Simon   +3 more
core   +2 more sources

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

open access: yesmedRxiv, 2020
Background No clinically proven effective antiviral strategy exists for the epidemic Coronavirus Disease 2019 (COVID-19). Methods We conducted a prospective, randomized, controlled, open-label multicenter trial involving adult patients with COVID-19 ...
Chang Chen   +13 more
semanticscholar   +1 more source

Prototype of running clinical trials in an untrustworthy environment using blockchain. [PDF]

open access: yes, 2019
Monitoring and ensuring the integrity of data within the clinical trial process is currently not always feasible with the current research system.
Bhattacharya, Sanchita   +2 more
core   +3 more sources

Research ethics consultation: an attempt and 5-year experience in a Japanese University Hospital

open access: yesBMC Research Notes, 2018
Objective Research ethics consultation is an advisory activity that differs from ethics committees, and its role is not yet widely known in Japan. Research ethics consultations were started in 2012 by members of the Clinical Trial Center of Tokushima ...
Hiroaki Yanagawa   +7 more
doaj   +1 more source

Tanshinone ΙΙA-Incubated Mesenchymal Stem Cells Inhibit Lipopolysaccharide-Induced Inflammation of N9 Cells through TREM2 Signaling Pathway

open access: yesStem Cells International, 2022
Our previous study found that incubating mesenchymal stem cells (MSC) with tanshinone IIA (TIIA) before transplantation could significantly increase the inhibitory effect of MSC on neuroinflammation.
Nanqu Huang   +5 more
doaj   +1 more source

Safety and Tolerability of an Antimalarial Herbal Remedy in Healthy Volunteers: An Open-Label, Single-Arm, Dose-Escalation Study on Maytenus senegalensis in Tanzania

open access: yesTropical Medicine and Infectious Disease, 2022
Background: Though Maytenus senegalensis is one of the medicinal plants widely used in traditional medicine to treat infectious and inflammatory diseases in Africa, there is a lack of safety data regarding its use.
Kamaka Kassimu   +25 more
doaj   +1 more source

Home - About - Disclaimer - Privacy